Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 2
1992 3
1993 4
1994 6
1995 2
1996 9
1997 7
1998 4
1999 7
2000 3
2001 2
2002 8
2003 8
2004 5
2005 7
2006 4
2007 7
2008 2
2009 1
2010 5
2011 4
2012 6
2013 6
2014 3
2015 5
2016 4
2017 1
2018 9
2019 4
2020 7
2021 6
2022 3
2023 6
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Results by year

Filters applied: . Clear all
Page 1
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, Richeldi L, Kolb M, Tetzlaff K, Stowasser S, Coeck C, Clerisme-Beaty E, Rosenstock B, Quaresma M, Haeufel T, Goeldner RG, Schlenker-Herceg R, Brown KK; INBUILD Trial Investigators. Flaherty KR, et al. N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29. N Engl J Med. 2019. PMID: 31566307 Clinical Trial.
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
Wells AU, Flaherty KR, Brown KK, Inoue Y, Devaraj A, Richeldi L, Moua T, Crestani B, Wuyts WA, Stowasser S, Quaresma M, Goeldner RG, Schlenker-Herceg R, Kolb M; INBUILD trial investigators. Wells AU, et al. Lancet Respir Med. 2020 May;8(5):453-460. doi: 10.1016/S2213-2600(20)30036-9. Epub 2020 Mar 5. Lancet Respir Med. 2020. PMID: 32145830 Clinical Trial.
Imaging methods for pulmonary sarcoidosis.
Węcławek M, Ziora D, Jastrzębski D. Węcławek M, et al. Among authors: ziora d. Adv Respir Med. 2020;88(1):18-26. doi: 10.5603/ARM.2020.0074. Adv Respir Med. 2020. PMID: 32153004 Free article. Review.
Adipokines in interstitial lung diseases.
Zielinski M, Chwalba A, Jastrzebski D, Ziora D. Zielinski M, et al. Among authors: ziora d. Respir Physiol Neurobiol. 2023 Sep;315:104109. doi: 10.1016/j.resp.2023.104109. Epub 2023 Jun 30. Respir Physiol Neurobiol. 2023. PMID: 37393966
[Advances in diagnosis of pulmonary sarcoidosis].
Ziora D, Jastrzębski D, Labus Ł. Ziora D, et al. Pneumonol Alergol Pol. 2012;80(4):355-64. Pneumonol Alergol Pol. 2012. PMID: 22714081 Free article. Review. Polish.
Guidelines of the Polish Respiratory Society on the Diagnosis and Treatment of Progressive Fibrosing Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis.
Piotrowski WJ, Martusewicz-Boros MM, Białas AJ, Barczyk A, Batko B, Błasińska K, Boros PW, Górska K, Grzanka P, Jassem E, Jastrzębski D, Kaczyńska J, Kowal-Bielecka O, Kucharz E, Kuś J, Kuźnar-Kamińska B, Kwiatkowska B, Langfort R, Lewandowska K, Mackiewicz B, Majewski S, Makowska J, Miłkowska-Dymanowska J, Puścińska E, Siemińska A, Sobiecka M, Soroka-Dąda RA, Szołkowska M, Wiatr E, Ziora D, Śliwiński P. Piotrowski WJ, et al. Among authors: ziora d. Adv Respir Med. 2022 Oct 4;90(5):425-450. doi: 10.3390/arm90050052. Adv Respir Med. 2022. PMID: 36285980 Free PMC article. Review.
157 results